Your search returned 50 studies. (Get alerts for new studies):
- Chemotherapy and Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Disease or Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- PXD101 and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Secondary Myelofibrosis - Small Intestine Cance
1 Location available
- Ondansetron Versus Aprepitant Plus Ondansetron for Emesis
Conditions: Hematologic Diseases - Acute Myelogenous Leukemia - Myelodysplastic Syndrome - Chronic Myelogenous Leukemia
1 Location available
- Sirolimus, Cyclosporine, and Mycophenolate Mofetil In Preventing Graft-Versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoi
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder - Adult Acute Lymphoblastic Leukemia in Remission - Adult
2 Locations available
- Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases - Nonmalignant Neoplasm - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol S
1 Location available
- Stem Cell Transplant for Hematologic Diseases
Conditions: Hematologic Malignancies
2 Locations available
- Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers
Conditions: Hematologic Diseases - Healthy Volunteers
2 Locations available
- Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Conditions: Metabolic Disorders - Hematologic, Immune, or Bone Marrow Disorders - Hemoglobinopathies
15 Locations available
- Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation
Conditions: Hematologic Malignancies - Nonmalignant Diseases - Immunodeficiencies - Hemoglobinopathies - Genetic Inborn Errors of Metabolism - Fanconi's Anemia, - Thalassemia - Sickle Cell Disease
1 Location available
- A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Conditions: Lymphoblastic Leukemia, Acute, Childhood - Myelogenous Leukemia, Acute, Childhood - Hodgkin's Disease - Non-Hodgkin's Lymphoma
1 Location available
- Cord Blood Transplantation for Patients With Cancer
Conditions: Hematological Disease
1 Location available
- Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease
Conditions: Graft vs Host Disease - Hematologic Neoplasm
1 Location available
- Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Myelodysplastic Syndromes - Secondary Myelofibrosis
1 Location available
- Evaluation, Treatment, and Training for Patients With Blood Disorders
Conditions: Hematologic Disease - Hematologic Neoplasm - Pancytopenia
1 Location available
- Natural History of Sickle Cell Disease and Other Hemolytic Disorders
Conditions: Hemoglobin SC Disease - Hematologic Diseases - Sickle Cell Anemia - Hemolytic Anemia
2 Locations available
- Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
Conditions: Hematologic Malignancies - Acute Myeloid Leukemia - Lymphoid Leukemia - Chronic Myeloid Leukemia - Hodgkin's Disease - Non-Hodgkin's Lymphoma - Myelodysplastic Syndromes
12 Locations available
- Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant
Conditions: Hematologic Malignancies - Graft vs Host Disease
2 Locations available
- A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies
Conditions: Hematologic Neoplasms - Leukemia - Lymphoma - Multiple Myeloma - Hodgkin's Disease
1 Location available
- Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases
Conditions: Chronic Leukemia - Acute Leukemia - Hodgkin's Disease - Non-Hodgkin's Lymphoma - Myelodysplastic Syndrome
1 Location available
- Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematologica
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Myeloid Leukemia in Remission - Adult Erythroleukemia (M6a) - Adult Nasal Type Extranodal NK/T-cell
1 Location available
- Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hemato
Conditions: Acute Myelogenous Leukemia - Acute Lymphocytic Leukemia - Myelodysplastic Syndrome
1 Location available
- Stem Cell Transplant for Hematological Malignancy
Conditions: Leukemia, Myeloid, Chronic - AML - Leukemia, Lymphocytic, Acute - MDS - Leukemia, Lymphocytic, Chronic - JMML - Hodgkin's Disease - Non-hodgkin's Lymphoma - Multiple Myeloma
1 Location available
- Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer o
Conditions: Graft Versus Host Disease - Leukemia - Myelodysplastic Syndromes
1 Location available
- Fludarabine, Melphalan, Total-Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Dis
Conditions: Chronic Myeloproliferative Disorders - Fanconi Anemia - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases - Nonmalignant Neoplasm - Paroxysmal Nocturnal Hemoglobinuria
1 Location available
- Sirolimus, Tacrolimus, Antithymocyte Globulin, and Rituximab in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancers or Other Dis
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
1 Location available
- Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
Conditions: Acute Myelogenous Leukemia - Acute Lymphocytic Leukemia - Chronic Lymphocytic Leukemia - Chronic Myelogenous Leukemia - Hodgkins Disease - Non-Hodgkins Lymphoma - Aplastic Anemia - Multiple Myeloma - Myelodysplastic Syndrome
1 Location available
- Laboratory-Treated Peripheral Blood Cell Infusion After Donor Stem Cell Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Conditions: Leukemia - Myelodysplastic Syndromes
5 Locations available
- Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Precancerous Condition - Secondary Myelofibrosis
1 Location available
- Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies
Conditions: Acute Lymphoblastic Leukemia (ALL) - Acute Myelogenous Leukemia (AML) - Myelodysplastic Syndrome (MDS) - Non-Hodgkin's Lymphoma - Hodgkin's Disease
2 Locations available
- Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transpl
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormali
5 Locations available
- Transplants With Unlicensed Preserved Cord Blood
Conditions: Myelodysplastic Syndrome (MDS) - Hematologic Neoplasms - Hematologic Diseases - Severe Aplastic Anemia
1 Location available
- Evaluation of Patients With Blood Disorders
Conditions: Hematologic Disease
1 Location available
- T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
Conditions: Hemophagocytic Lymphohistiocytosis - X-Linked Lymphoproliferative Disorders - Chediak-Higashi Syndrome - Griscelli Syndrome - Immunologic Diseases - Langerhans-Cell Histiocytosis - Hematologic Diseases
1 Location available
- Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases
Conditions: Leukemia - Myelodysplastic Syndromes
24 Locations available
- Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
3 Locations available
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Ca
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
5 Locations available
- Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Conditions: Cancer - Hematologic Malignancies - Multiple Myeloma - Oncology - Bone Metastases - Multiple Myeloma Bone Lesions
9 Locations available
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Conditions: Hematological Malignancies - Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders - Hurler Syndrome (MPS I) - Krabbe Disease (Globoid Leukodystrophy) - X-linked Adrenoleukodystrophy - Primary Immunodeficiency Diseases - Bone Marrow Failur
123 Locations available
- Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical C
Conditions: Cord Blood Transplant - Hematologic Malignancy - Inherited Metabolic Disease
1 Location available
- Bone Marrow Grafting for Leukemia and Lymphoma
Conditions: Leukemia - Lymphoma - Hematologic Diseases
1 Location available
- Fludarabine, Busulfan, and Alemtuzumab Followed By Donor Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disease
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Precancerous Condition
2 Locations available
- T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
Conditions: Acute Myelogenous Leukemia - Lymphoid Leukemia - Chronic Myelogenous Leukemia - Malignant Lymphoma - Hodgkin's Disease - Chronic Lymphocytic Leukemia - Myeloproliferative Disorder - Anemia, Aplastic - Myelodysplastic Syndromes
1 Location available
- Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Leukemia, Myeloid, Accelerated Phase - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Blast Phase - Contiguous Stage II Adult Burkitt's Lymphoma - Contiguous S
1 Location available
- Integrated Whole-Genome Analysis of Hematologic Disorders
Conditions: Hematologic Diseases
1 Location available
- Gulf Long-Term Follow-Up Study
Conditions: Cardiovascular Disease - Hematologic Diseases - Immunologic Disease - Cancer - Respiratory Function
1 Location available
- Ultra Low Dose Interleukin-2 in Healthy Volunteers
Conditions: Hematologic Diseases
1 Location available
|